Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 114 publications
GLP-1 and MASH: When weight loss isn't the whole story.
Journal: Cell metabolism
Published: June 01, 2026
A reasonably likely surrogate endpoint for metabolic dysfunction-associated steatohepatitis.
Journal: Nature medicine
Published: April 28, 2026
EQ-5D Health Utility Gains with Once-Weekly Semaglutide 2.4 mg in People with MASH and F2/F3 Fibrosis: An Analysis of ESSENCE.
Journal: JHEP reports : innovation in hepatology
Published: March 05, 2026
Cumulative lipid exposure in young adulthood and risk of midlife MASLD.
Journal: JHEP reports : innovation in hepatology
Published: October 12, 2025
Semaglutide on liver fibrosis and heart outcomes in patients at high risk of liver fibrosis: a prespecified analysis of the SELECT randomized trial.
Journal: Nature medicine
Published: September 19, 2025
CT-adipose measures identify severe SARS-CoV-2 risk beyond traditional obesity metrics: a C4R cohort study.
Journal: BMC pulmonary medicine
Published: June 02, 2025
Circulating Proteomics Identifies a Dynamic Profile of Hepatic Steatosis During Metabolic Intervention.
Journal: Journal of the American Heart Association
Published: May 15, 2025
Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis.
Journal: The New England journal of medicine
Published: April 30, 2025
Assessing Clinician Engagement With a Passive Clinical Decision Support System for Liver Fibrosis Risk Stratification in a Weight Management Clinic.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Published: February 14, 2025
Physical Activity by Accelerometer Inversely Associated With Liver Fibrosis; Cross-Sectional Analysis of a Longitudinal Cohort.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: February 14, 2025
Is There an Association Between Cigarette Smoking and Advanced Liver Fibrosis in Smokers with HIV, Heavy Drinking and High Prevalence of HCV?
Journal: Journal of clinical medicine
Published: December 04, 2024
Proteomic signatures reflect effects of semaglutide treatment for MASH.
Journal: JHEP reports : innovation in hepatology
Published: November 21, 2024
Last Updated: 09/26/2026